Product Name: Human Complement C5 Antibody (Pozelimab, Research Use)
Catalog Number: NBR-0820
Target Name: Complement C5
Trade Name: Pozelimab
Antibody Drug Description: Pozelimab is an investigational, fully human, monoclonal antibody designed to block the activity of complement factor C5 and prevent diseases mediated by the complement pathway. It is an IgG4 antibody that binds with high affinity to wild-type and variant human C5. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: C5
Synonyms: C5a; C5b; CPAMD4
Target Description: Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.
Ensembl: ENSG00000106804
Uniprot: P01031